September 23, 2019

EASD special: conference roundup

30 minutes

A series of expert interviews conducted at EASD 2019. This includes:

Professor Steve Bain, discussing the PIONEER trials of oral semaglutide

Professor Dr Thomas Danne, discussing approaches to type 1 diabetes management

Professor Jens Juul Holst, discussing gastric peptides as actionable targets

Professor Didac Maruicio, discussing the CONCLUDE trial

This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.

...more